16 Jun 2026
Deal: Trilegal advised Aurobindo Pharma Group on the acquisition of the branded non-oncology prescription formulations business of KLabs
02 Jan 2026
02 Jan 2026
Trilegal advised Auro Pharma Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, on its acquisition of the branded non-oncology prescription formulation business of Khandelwal Laboratories Private Limited on a slump sale basis.
The acquisition strengthens Aurobindo Pharma Group’s domestic branded formulations platform by adding established brands in the pain management and anti-infective segments, complementing its existing product portfolio and supporting further expansion in the Indian pharmaceutical market.
Trilegal provided end-to-end legal support on the transaction, including conducting legal due diligence, drafting and negotiating the transaction documents, and assisting with closing.
The Trilegal Transaction Team advising on the matter was led by Partner: Siddharth Dang; and supported by Senior Associate: Rutvi Shrimankar; and Associates: Sanchit Thapliyal, Rohan Singhal, Shubh Jaiswal.
The Trilegal Intellectual Property Team advising on the matter was led by Partner: Kirti Balasubramanian and supported by Associate: Hitarth Parikh.
The Trilegal Labour & Employment Team advising on the matter was led by Partner: Parvathy Tharamel; and supported by Associates: Koshy Mathen, Gokul Suresh Nair.
The Trilegal Due Diligence Team advising on the matter was led by Partners: Siddharth Dang, Ankit Kejriwal, Kirti Balasubramanian, and Parvathy Tharamel; and supported by Senior Associates: Rutvi Shrimankar, Rutvij Naik; and Associates: Sanchit Thapliyal, Shubh Jaiswal, Hitarth Parikh, Dhanush T, Koshy Mathen, Gokul Suresh Nair.
About Trilegal
Trilegal is a leading full-service law firm in India with over 25 years of experience, trusted for its in-depth expertise and client-centric approach. The firm advises a diverse set of clients, including Fortune 500 companies, global investment funds, major Indian conglomerates, domestic and international banks, technology and media giants, family offices, and high-net-worth individuals. With 150 partners operating under a distinctive lockstep model, Trilegal is the largest equity partnership in the country. The firm retains over 1,200 professionals across Mumbai, Delhi, Bengaluru, and Gurugram offices.
Trilegal has consistently been recognised among India’s top-tier firms in leading legal directories such as Chambers & Partners (Asia Pacific and Global), Legal 500 Asia Pacific, and Benchmark Litigation. It has also earned several prestigious accolades, including being named Best Overall Law Firm by India Business Law Journal (IBLJ) 2025, Innovative Lawyers in Disputes & Crisis Management by the Financial Times (FT) Innovative Lawyers Asia-Pacific Awards in 2025, M&A Firm of the Year by IFLR Asia-Pacific in 2024, Law Firm of the Year by Deal Volume at the VCCircle Awards in 2024.
For more information, please get in touch with Prakruti Jani | Mob: +91-9867868976 | BD@trilegal.com.
Trilegal expands its Intellectual Property practice with the addition of two new Partners
Deal: Trilegal advised Indus Infra Trust on its Institutional Placement (IP) and preferential allotment aggregating to approximately INR 2,000 crore First institutional placement by a road InvIT for the acquisition of third-party assets
Deal: Trilegal advises Kimbal on its Series B fundraise from GEF Capital Partners and Niveshaay Sambhav Fund
Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:
We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:
For more information, please read our terms of use and our privacy policy.
